NCT06353191View on ClinicalTrials.gov

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (4)

33612

RECRUITING

Moffitt Cancer Center, Tampa

55905

SUSPENDED

Mayo Clinic in Rochester, Rochester

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT06353191 - Biomarkers to Predict Cancer Therapy-related Cardiotoxicity | Biotech Hunter | Biotech Hunter